Platelet-derived microparticles

Platelets

Volumn , Issue , 2007, Pages 403-413

  Nieuwland, Rienk ^a   Sturk, Augueste ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 74349109317     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50782-5     Document Type: Chapter

References (77)

1. Chargaff E., West R. The biological significance of the thromboplastic protein of blood. J Biol Chem 1946, 166:189-197.
2. O'Brian J.R. The platelet-like-activity of serum. Br J Haematol 1995, 1:223-228.
3. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13:269-288.
4. Heijnen H.F., Schiel A.E., Fijnheer R., et al. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94:3791-3799.
5. Schroit A.J., Zwaal R.F. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991, 1071:313-329.
6. Bevers E.M., Comfurius P., Dekkers D.W., et al. Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta 1999, 1439:317-330.
7. Bevers E.M., Comfurius P., Zwaal R.F. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983, 736:57-66.
8. Chang C.P., Zhao J., Wiedmer T., et al. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993, 268:7171-7178.
9. Sims P.J., Wiedmer T., Esmon C.T., et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 1989, 264:17049-17057.
10. Jin M., Drwal G., Bourgeois T., et al. Distinct proteome features of plasma microparticles. Proteomics 2005, 5:1940-1952.
11. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997, 96:3534-3541.
12. Nieuwland R., Berckmans R.J., McGregor S., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000, 95:930-935.
13. Berckmans R.J., Nieuwland R., Böing A.N., et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85:639-646.
14. Combes V., Simon A.C., Grau G.E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999, 104:93-102.
15. Berckmans R.J., Nieuwland R., Tak P.P., et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 2002, 46:2857-2866.
16. Biró É., Nieuwland R., Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1843-1844.
17. Aupeix K., Hugel B., Martin T., et al. The signifi-cance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997, 99:1546-1554.
18. Miyamoto S., Marcinkiewicz C., Edmunds L.H., et al. Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/ IIIa. Thromb Haemost 1998, 80:225-230.
19. Miyazaki Y., Nomura S., Miyake T., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996, 88:3456-3464.
20. Holme P.A., Orvim U., Hamers M.J., et al. Shearinduced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997, 17:646-653.
21. Gemmell C.H., Ramirez S.M., Yeo E.L., et al. Platelet activation in whole blood by artificial surfaces: Iden-tification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. J Lab Clin Med 1995, 125:276-287.
22. Sims P.J., Faioni E.M., Wiedmer T., et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988, 263:18205-18212.
23. Bode A.P., Knup C.L. Effect of cold storage on platelet glycoprotein Ib and vesiculation. Transfusion 1994, 34:690-696.
24. Gemmell C.H., Sefton M.V., Yeo E.L. Plateletderived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 1993, 268:14586-14589.
25. Holme P.A., Solum N.O., Brosstad F., et al. Stimulated Glanzmann's thrombas thenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa. Thromb Haemost 1995, 74:1533-1540.
26. Fox J.E., Austin C.D., Reynolds C.C., et al. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991, 266:13289-13295.
27. Shcherbina A., Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999, 93:4222-4231.
28. Wiedmer T., Shattil S.J., Cunningham M., et al. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990, 29:623-632.
29. Pasquet J.M., Dachary-Prigent J., Nurden A.T. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J 1998, 333:591-599. (Pt 3).
30. Bode A.P., Orton S.M., Frye M.J., et al. Vesiculation of platelets during in vitro aging. Blood 1991, 77:887-895.
31. Wolf B.B., Goldstein J.C., Stennicke H.R., et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999, 94:1683-1692.
32. Abid Hussein M.N., Nieuwland R., Hau C.M., et al. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost 2005, 3:888-896.
33. Sebbagh M., Renvoize C., Hamelin J., et al. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001, 3:346-352.
34. Wiedmer T., Hall S.E., Ortel T.L., et al. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993, 82:1192-1196.
35. Cramer E.M., Norol F., Guichard J., et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997, 89:2336-2346.
36. Del Conde I., Shrimpton C.N., Thiagarajan P., et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005, 106:1604-1611.
37. Diamant M., Tushuizen M.E., Sturk A., et al. Cellular microparticles: New players in the field of vascular disease?. Eur J Clin Invest 2004, 34:392-401.
38. Tans G., Rosing J., Thomassen M.C., et al. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991, 77:2641-2648.
39. Taube J., McWilliam N., Luddington R., et al. Activated protein C resistance: Effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood 1999, 93:3792-3797.
40. Joop K., Berckmans R.J., Nieuwland R., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001, 85:810-820.
41. Merten M., Pakala R., Thiagarajan P., et al. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999, 99:2577-2582.
42. Forlow S.B., McEver R.P., Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000, 95:1317-1323.
43. Barry O.P., Pratico D., Lawson J.A., et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997, 99:2118-2127.
44. Barry O.P., Kazanietz M.G., Pratico D., et al. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999, 274:7545-7556.
45. Iwamoto S., Kawasaki T., Kambayashi J., et al. Platelet microparticles: A carrier of platelet-activating factor?. Biochem Biophys Res Commun 1996, 218:940-944.
46. Boulanger C.M., Scoazec A., Ebrahimian T., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001, 104:2649-2652.
47. VanWijk M.J., Svedas E., Boer K., et al. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 2002, 187:1686-1693.
48. Pfister S.L. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004, 43:428-433.
49. Celi A., Pellegrini G., Lorenzet R., et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1994, 91:8767-8771.
50. Kim H.K., Song K.S., Chung J.H., et al. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004, 124:376-384.
51. Weber A., Koppen H.O., Schror K. Plateletderived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000, 98:461-466.
52. Weiss H.J., Vicic W.J., Lages B.A., et al. Isolated deficiency of platelet procoagulant activity. Am J Med 1979, 67:206-213.
53. Toti F., Satta N., Fressinaud E., et al. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996, 87:1409-1415.
54. Dachary-Prigent J., Pasquet J.M., Fressinaud E., et al. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: A study using physiologic agonists and local anaesthetics. Br J Haematol 1997, 99:959-967.
55. Bettache N., Gaffet P., Allegre N., et al. Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome. Br J Haematol 1998, 101:50-58.
56. Brooks M.B., Catalfamo J.L., Brown H.A., et al. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 2002, 99:2434-2441.
57. Castaman G., Yu-Feng L., Battistin E., et al. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997, 96:458-463.
58. Shcherbina A., Rosen F.S., Remold-O'Donnell E. Pathological events in platelets of Wiskott-Aldrich syndrome patients. Br J Haematol 1999, 106:875-883.
59. Jy E., Horstman L.L., Arce M., et al. Clinical signifi cance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992, 119:334-345.
60. Lee Y.J., Jy W., Horstman L.L., et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993, 72:295-304.
61. Nomura S., Komiyama Y., Miyake T., et al. Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 1994, 72:519-522.
62. Visentin G.P., Ford S.E., Scott J.P., et al. Antibodies from patients with heparin-induced thrombocytopenia/ thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994, 93:81-88.
63. Warkentin T.E. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfus Med Rev 1996, 10:249-258.
64. Warkentin T.E., Hayward C.P., Boshkov L.K., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994, 84:3691-3699.
65. Morel O., Jesel L., Chauvin M., et al. Eptifi batideinduced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome. J Thromb Haemost 2003, 1:2685-2687.
66. Biró É., Sturk-Maquelin K.N., Vogel G.M., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003, 1:2561-2568.
67. McGill M., Fugman D.A., Vittorio N., et al. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med 1987, 109:127-133.
68. Katopodis J.N., Kolodny L., Jy W., et al. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997, 54:95-101.
69. Nomura S., Suzuki M., Katsura K., et al. Plateletderived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995, 116:235-240.
70. Larsson A., Nilsson B., Eriksson M. Thrombocytopenia and platelet microvesicle formation caused by Legionella pneumophila infection. Thromb Res 1999, 96:391-397.
71. Nomura S., Shouzu A., Nishikawa M., et al. Signifi-cance of platelet-derived micro particles in uremia. Nephron 1993, 63:485.
72. Wun T., Paglieroni T., Rangaswami A., et al. Platelet activation in patients with sickle cell disease. Br J Haematol 1998, 100:741-749.
73. Kelton J.G., Moore J.C., Warkentin T.E., et al. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura. Br J Haematol 1996, 93:421-426.
74. Horstman L.L., Ahn Y.S. Platelet microparticles: A wide-angle perspective. Crit Rev Oncol Hematol 1999, 30:111-142.
75. George J.N., Pickett E.B., Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986, 68:307-309.
76. Chao F.C., Kim B.K., Houranieh A.M., et al. Infusible platelet membrane microvesicles: A potential transfusion substitute for platelets. Transfusion 1996, 36:536-542.
77. Proulle V., Hugel B., Guillet B., et al. Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles. Thromb Haemost 2004, 91:873-878.